Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
Keith C HayesDepartment of Physical Medicine and Rehabilitation, The University of Western Ontario, London, ON, CanadaAbstract: Dalfampridine extended release (ER) 10 mg is an oral tablet form of the potassium (K+) channel-blocking compounded dalfampridine, also known as fampridine, and chemically&a...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ca611cb145b34bab91b18fb7e442dcf5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|